Champions Oncology (CSBR) Cash from Operations Growth (1y) (2011 - 2026)
Champions Oncology (CSBR) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-15.72% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Champions Oncology |
78.46 Mn |
71.46 Mn |
13.89 Mn |
-373.27% |
| Date | Value |
|---|
| Jan 31, 2026 |
-373.27% |
| Oct 31, 2025 |
-513.07% |
| Jul 31, 2025 |
92.93% |
| Apr 30, 2025 |
478.19% |
| Jan 31, 2025 |
153.32% |
| Oct 31, 2024 |
-148.05% |
| Jul 31, 2024 |
107.79% |
| Apr 30, 2024 |
-162.43% |
| Jan 31, 2024 |
-158.42% |
| Oct 31, 2023 |
-82.08% |
| Jul 31, 2023 |
-1,946.67% |
| Apr 30, 2023 |
-186.93% |
| Jan 31, 2023 |
-63.05% |
| Oct 31, 2022 |
167.59% |
| Jul 31, 2022 |
-190.28% |
| Apr 30, 2022 |
140.20% |
| Jan 31, 2022 |
3,053.33% |
| Oct 31, 2021 |
39.70% |
| Jul 31, 2021 |
130.21% |
| Apr 30, 2021 |
-177.80% |
